Exact Mass: 495.08888720000004
Exact Mass Matches: 495.08888720000004
Found 55 metabolites which its exact mass value is equals to given mass value 495.08888720000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Isopentenyl-ADP
C15H23N5O10P2 (495.09201179999997)
A purine ribonucleoside 5-diphosphate that is ADP substituted at position N-6 by a dimethylallyl (isopentenyl) group.
3-Azetidinecarboxamide, 1-(7-(2-chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo(1,5-a)-1,3,5-triazin-4-yl)-3-(ethylamino)-
High Temperature Requirement A2 Inhibitor I
C27H17N3O5S (495.08888720000004)
1,3,6-O-trinicotinoyl-alpha-D-glucopyranose
C24H21N3O9 (495.12777360000007)
N-(2-beta-D-glucopyranosyl-5-hydroxysalicyl)-5-hydroxy-6-methoxyanthranilic acid methyl ester
1,2-dihydro-6-hydroxy-3,4-dimethyl-2-oxo-5-[[4-(phenylazo)phenyl]azo]-1,3-bipyridinium chloride
C24H21Cl2N6O2 (495.11029659999997)
4-((4-(DIETHYLAMINO)-2-HYDROXYPHENYL)DIAZENYL)-5-HYDROXYNAPHTHALENE-2,7-DISULFONIC ACID
4-[(2,5-dichlorophenyl)azo]-N-(2,5-dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide
C25H19Cl2N3O4 (495.07525540000006)
(Z)-3-(((4-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-6-iodoindolin-2-one
(N-methyl-n-phenylamino)triphenylphosphonium iodide
High Temperature Requirement A2 Inhibitor I
C27H17N3O5S (495.08888720000004)
N-(3-methoxyphenyl)-2-{(2Z)-4-oxo-3-phenyl-2-[(phenylsulfonyl)imino]-1,3-thiazolidin-5-yl}acetamide
C24H21N3O5S2 (495.09225760000004)
(2S)-2-[(2,4-Dichloro-benzoyl)-(3-trifluoromethyl-benzyl)-amino]-3-phenyl-propionic acid
C24H18Cl2F3NO3 (495.06157740000003)
N(6)-(Dimethylallyl)adenosine 5-diphosphate
C15H23N5O10P2 (495.09201179999997)
2-amino-3-hydroxy-4-methylbenzoyl-AMP(1-)
C18H20N6O9P- (495.10293400000006)
An organophosphate oxoanion obtained by deprotonation of the phosphate OH group of 2-amino-3-hydroxy-4-methylbenzoyl-AMP; the major species at pH 7.3.
[(5E)-5-sulfooxyimino-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylpentyl] benzoate
C18H25NO11S2 (495.08689799999996)
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(1H-indol-3-ylmethylcarbamothioylsulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(6-chloro-2-phenylpyrimidin-4-yl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
C20H22ClN5O6S (495.0979262000001)
2-[[3-(3,4-dichlorophenyl)-4-oxo-2-quinazolinyl]thio]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
C25H19Cl2N3O2S (495.05749740000005)
2-chloro-N-(2,3-dihydro-1H-inden-5-yl)-5-[(4-phenyl-1-piperazinyl)sulfonyl]benzamide
C26H26ClN3O3S (495.13833160000013)
N-(4-ethoxyphenyl)sulfonyl-N-(2-oxo-5-benzo[g][1,3]benzoxathiolyl)-2-furancarboxamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3-[4-[(1S,5R)-3-(3-chlorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
C26H26ClN3O3S (495.13833160000013)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
(6R,7R)-7-[3-(difluoromethylsulfanyl)-2-oxopropyl]-3-[[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
N(6)-(Dimethylallyl)adenosine 5'-diphosphate
C15H23N5O10P2 (495.09201179999997)
IPI-9119
IPI-9119 is an orally active, selective and irreversible FASN inhibitor with an IC50 of 0.3 nM in vitro biochemical assay. IPI-9119 inhibits tumor growth of castration-resistant prostate cancer (CRPC) xenografts mouse models[1][2].
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(6-hydroxy-4,7-diphenyl-1,3-benzothiazol-5-yl)oxy]oxane-2-carboxylic acid
C25H21NO8S (495.09878260000005)
2,5-dimethyl 3,4-bis(5-chloro-1h-indol-3-yl)-1-methylpyrrole-2,5-dicarboxylate
C25H19Cl2N3O4 (495.07525540000006)